Cancer epigenetics reaches mainstream oncology

Chromatin modifications and their function

Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405

DNA methylation patterns and epigenetic memory

Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124

High-Resolution Profiling of Histone Methylations in the Human Genome

Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845

Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836

Human DNA methylomes at base resolution show widespread epigenomic differences

Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., Nery, J. R., Lee, L., Ye, Z., Ngo, Q.-M., et al. (2009) · Nature · doi:10.1038/nature08514 · Cited by 4,673

The Epigenomics of Cancer

Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells

Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129

Epigenetics in Cancer

Esteller, M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072067 · Cited by 3,662

The Role of Chromatin during Transcription

Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,533

Gene Silencing in Cancer in Association with Promoter Hypermethylation

Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422

DNA methylation landscapes: Provocative insights from epigenomics

Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039

Anticancer activities of histone deacetylase inhibitors

Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770

Genome-scale DNA methylation maps of pluripotent and differentiated cells

Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., Jaffe, D. B., et al. (2008) · Nature · doi:10.1038/nature07107 · Cited by 2,536

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification

Ito, S., D’Alessio, A. C., Taranova, O. V., Hong, K., Sowers, L. C., & Zhang, Y. (2010) · Nature · doi:10.1038/nature09303 · Cited by 2,373

Cancer-epigenetics comes of age

Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

Noushmehr, H., Weisenberger, D. J., Diefes, K., Phillips, H. S., Pujara, K., Berman, B. P., Pan, F., Pelloski, C. E., Sulman, E. P., Bhat, K. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.017 · Cited by 2,337

Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents

Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224

The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177

Cancer epigenomics: DNA methylomes and histone-modification maps

Esteller, M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2005 · Cited by 2,146

A gene hypermethylation profile of human cancer.

Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032

DNMT3A Mutations in Acute Myeloid Leukemia

Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., Lamprecht, T., Larson, D. E., Kandoth, C., Payton, J. E., Baty, J., Welch, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1005143 · Cited by 1,983

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

Gottlicher, M. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,887

An operational definition of epigenetics: Figure 1.

Berger, S. L., Kouzarides, T., Shiekhattar, R., & Shilatifard, A. (2009) · Genes & Development · doi:10.1101/gad.1787609 · Cited by 1,884

Mutation in TET2 in Myeloid Cancers

Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776

Principles and challenges of genome-wide DNA methylation analysis

Laird, P. W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2732 · Cited by 1,572

The power and the promise of DNA methylation markers

Laird, P. W. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1045 · Cited by 1,562

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Morin, R. D., Johnson, N. A., Severson, T. M., Mungall, A. J., An, J., Goya, R., Paul, J. E., Boyle, M., Woolcock, B. W., Kuchenbauer, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.518 · Cited by 1,521

Chromosomal Instability and Tumors Promoted by DNA Hypomethylation

Eden, A., Gaudet, F., Waghmare, A., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083557 · Cited by 1,399

Aberrant CpG-island methylation has non-random and tumour-type–specific patterns

Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., & Jones, P. A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.020 · Cited by 1,335

Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.

Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253

MLL translocations, histone modifications and leukaemia stem-cell development

Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

Ko, M., Huang, Y., Jankowska, A. M., Pape, U. J., Tahiliani, M., Bandukwala, H. S., An, J., Lamperti, E. D., Koh, K. P., Ganetzky, R., et al. (2010) · Nature · doi:10.1038/nature09586 · Cited by 1,213

Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts

Doi, A., Park, I.-H., Wen, B., Murakami, P., Aryee, M. J., Irizarry, R., Herb, B., Ladd-Acosta, C., Rho, J., Loewer, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.471 · Cited by 1,177

Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers

Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099

Global histone modification patterns predict risk of prostate cancer recurrence

Seligson, D. B., Horvath, S., Shi, T., Yu, H., Tze, S., Grunstein, M., & Kurdistani, S. K. (2005) · Nature · doi:10.1038/nature03672 · Cited by 1,092

A microRNA DNA methylation signature for human cancer metastasis

Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sánchez-Céspedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803055105 · Cited by 1,078

Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

Fang, M., Wang, Y., Ai, N., Hou, Z., Sun, Y., Lu, H., Welsh, W. J., & Yang, C. S. (2003) · PubMed · Cited by 1,049

Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1

Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205670200 · Cited by 1,002

New nomenclature for chromatin-modifying enzymes

Allis, C. D., Berger, S. L., Cote, J., Dent, S., Jenuwien, T., Kouzarides, T., Pillus, L., Reinberg, D., Shi, Y., Shiekhattar, R., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.039 · Cited by 957

Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells

Lujambio, A., Ropero, S., Ballestar, E., Fraga, M. F., Cerrato, C., Setién, F., Casado, S., Suarez-Gauthier, A., Sanchez-Cespedes, M., Gitt, A., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4218 · Cited by 939

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.

Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · cited 1×

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

Lee, W. H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W. S., Isaacs, W. B., & Nelson, W. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11733 · Cited by 838

Curcumin, a Novel p300/CREB-binding Protein-specific Inhibitor of Acetyltransferase, Represses the Acetylation of Histone/Nonhistone Proteins and Histone Acetyltransferase-dependent Chromatin Transcription

Balasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832

DNA hypomethylation and human diseases

Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

Weller, M., Stupp, R., Reifenberger, G., Brandes, A. A., van den Bent, M. J., Wick, W., & Hegi, M. E. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.197 · Cited by 778

Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

Piekarz, R. L., Frye, R., Turner, M., Wright, J. J., Allen, S. L., Kirschbaum, M. H., Zain, J., Prince, H. M., Leonard, J. P., Geskin, L. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6150 · Cited by 740

SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells

Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F. P., Li, M., Yagyu, R., & Nakamura, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1151 · Cited by 731

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

Khan, N., Jeffers, M., Kumar, S., Hackett, C., Boldog, F., Khramtsov, N., Qian, X., Mills, E., Berghs, S. C., Carey, N., et al. (2008) · Biochemical Journal · doi:10.1042/bj20070779 · Cited by 713

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

Ogawa, O., Eccles, M. R., Szeto, J., McNoe, L. A., Yun, K., Maw, M. A., Smith, P. J., & Reeve, A. E. (1993) · Nature · doi:10.1038/362749a0 · Cited by 707

Histone H3 serine 10 phosphorylation by Aurora B causes HP1 dissociation from heterochromatin

Hirota, T., Lipp, J. J., Toh, B.-H., & Peters, J.-M. (2005) · Nature · doi:10.1038/nature04254 · Cited by 659

JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin

Dawson, M. A., Bannister, A. J., Göttgens, B., Foster, S. D., Bartke, T., Green, A. R., & Kouzarides, T. (2009) · Nature · doi:10.1038/nature08448 · Cited by 622

Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells

Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610

Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer

Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600

DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer

Brock, M. V., Hooker, C. M., Ota-Machida, E., Han, Y., Guo, M., Ames, S., Glöckner, S., Piantadosi, S., Gabrielson, E., Pridham, G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706550 · Cited by 593

Mutations truncating the EP300 acetylase in human cancers

Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587

W. H. Fox Talbot and the history of photography

Gernsheim, H. (1977) · Endeavour · doi:10.1016/0160-9327(77)90005-9 · Cited by 564

Polyisoprenylated Benzophenone, Garcinol, a Natural Histone Acetyltransferase Inhibitor, Represses Chromatin Transcription and Alters Global Gene Expression

Balasubramanyam, K., Altaf, M., Varier, R. A., Swaminathan, V., Ravindran, A., Sadhale, P. P., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402839200 · Cited by 546

Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening

Grozinger, C. M., Chao, E. D., Blackwell, H. E., Moazed, D., & Schreiber, S. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106779200 · Cited by 539

Gene-promoter hypermethylation as a biomarker in lung cancer

Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533

Polycomb group proteins: navigators of lineage pathways led astray in cancer

Bracken, A. P., & Helin, K. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2736 · Cited by 523

Discovery, In Vivo Activity, and Mechanism of Action of a Small-Molecule p53 Activator

Lain, S., Hollick, J. J., Campbell, J., Staples, O. D., Higgins, M., Aoubala, M., McCarthy, A., Appleyard, V., Murray, K. E., Baker, L., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.004 · Cited by 522

Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9

Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521

The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases

Yang, X.-J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh252 · Cited by 515

Sirtuins: critical regulators at the crossroads between cancer and aging

Saunders, L. R., & Verdin, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210616 · Cited by 489

Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter

Plumb, J. A., Strathdee, G. R., Sludden, J., Kaye, S. B., & Brown, R. E. (2000) · PubMed · doi:10.25405/ncl.34284429 · Cited by 486

The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade

Weigelt, B., Baehner, F. L., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2648 · Cited by 482

Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes

Heltweg, B., Gatbonton, T., Schuler, A. D., Posakony, J., Li, H., Goehle, S., Kollipara, R., DePinho, R. A., Gu, Y., Simon, J. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3617 · Cited by 469

Curcumin (diferuloylmethane) inhibits constitutive NF-κB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma

Shishodia, S., Amin, H. M., Lai, R., & Aggarwal, B. B. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.043 · Cited by 459

Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma

Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A. F., Simon, M., Dietrich, P.-Y., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.6650 · Cited by 454

Role for DNA methylation in the control of cell type–specific maspin expression

Futscher, B. W., Oshiro, M. M., Wozniak, R. J., Holtan, N., Hanigan, C. L., Duan, H., & Domann, F. E. (2002) · Nature Genetics · doi:10.1038/ng886 · Cited by 442

Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications

Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., & Shiekhattar, R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.004 · Cited by 438

NUP98–NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis

Wang, G. G., Cai, L., Pasillas, M. P., & Kamps, M. P. (2007) · Nature Cell Biology · doi:10.1038/ncb1608 · Cited by 437

Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras–MAPK signaling in human cancer cells

Ota, H., Tokunaga, E., Chang, K., Hikasa, M., Iijima, K., Eto, M., Kozaki, K., Akishita, M., Ouchi, Y., & Kaneki, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209049 · Cited by 435

Role of Curcumin in Cancer Therapy

Shishodia, S., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.04.001 · Cited by 413

New insights to the MLL recombinome of acute leukemias

Meyer, C., Kowarz, E., Hofmann, J., Renneville, A., Zuna, J., Trka, J., Ben Abdelali, R., Macintyre, E., De Braekeleer, E., De Braekeleer, M., et al. (2009) · Leukemia · doi:10.1038/leu.2009.33 · Cited by 407

Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid in Patients With Advanced Hematologic Malignancies

O'Connor, O. A., Heaney, M. L., Schwartz, L., Richardson, S., Willim, R., MacGregor-Cortelli, B., Curly, T., Moskowitz, C., Portlock, C., Horwitz, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9679 · Cited by 404

Regulation of Tumor Angiogenesis by EZH2

Lu, C., Han, H. D., Mangala, L. S., Ali-Fehmi, R., Newton, C. S., Ozbun, L., Armaiz-Pena, G. N., Hu, W., Stone, R. L., Munkarah, A., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.016 · Cited by 399

A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia

Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-05-1693 · Cited by 398

Epigenetic Control of Mouse Oct-4 Gene Expression in Embryonic Stem Cells and Trophoblast Stem Cells

Hattori, N., Nishino, K., Ko, Y.-G., Hattori, N., Ohgane, J., Tanaka, S., & Shiota, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309002200 · Cited by 397

Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk Cohort

Belinsky, S. A., Liechty, K. C., Gentry, F. D., Wolf, H. J., Rogers, J., Vu, K., Haney, J., Kennedy, T. C., Hirsch, F. R., Miller, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3408 · Cited by 389

Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation

Pruitt, K., Zinn, R. L., Ohm, J. E., McGarvey, K. M., Kang, S.-H. L., Watkins, D. N., Herman, J. G., & Baylin, S. B. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020040 · Cited by 387 · cited 1×

Detection in Fecal DNA of Colon Cancer–Specific Methylation of the Nonexpressed Vimentin Gene

Chen, W.-D., Han, Z. J., Skoletsky, J., Olson, J., Sah, J., Myeroff, L., Platzer, P., Lu, S., Dawson, D., Willis, J., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji204 · Cited by 370

Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia.

Esteller, M., Corn, P. G., Ureña, J. M., Gabrielson, E. W., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 356

Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation

Mukhopadhyay, A., Banerjee, S., Stafford, L. J., Xia, C., Liu, M., & Aggarwal, B. B. (2002) · Oncogene · doi:10.1038/sj.onc.1206048 · Cited by 353

Identification of a small molecule inhibitor of Sir2p

Bedalov, A., Gatbonton, T., Irvine, W. P., Gottschling, D. E., & Simon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.261574398 · Cited by 346

Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice

Howard, G., Eiges, R., Gaudet, F., Jaenisch, R., & Eden, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210631 · Cited by 343

Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response

Gorrini, C., Squatrito, M., Luise, C., Syed, N., Perna, D., Wark, L., Martinato, F., Sardella, D., Verrecchia, A., Bennett, S., et al. (2007) · Nature · doi:10.1038/nature06055 · Cited by 343

Sensitive digital quantification of DNA methylation in clinical samples

Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341

Small Molecule Regulators of Protein Arginine Methyltransferases

Cheng, D., Yadav, N., King, R. W., Swanson, M. S., Weinstein, E. J., & Bedford, M. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401853200 · Cited by 339

Chromosomal Instability Correlates with Genome-wide DNA Demethylation in Human Primary Colorectal Cancers

Rodriguez, J., Frigola, J., Vendrell, E., Risques, R.-A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capellà, G., Ribas, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0293 · Cited by 335

MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo

Fournel, M., Bonfils, C., Hou, Y., Yan, P. T., Trachy-Bourget, M.-C., Kalita, A., Liu, J., Lu, A.-H., Zhou, N. Z., Robert, M.-F., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2026 · Cited by 332

Targeting DNA methylation for epigenetic therapy

Yang, X., Lay, F., Han, H., & Jones, P. A. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.08.001 · Cited by 326

The DNA Methylome of Human Peripheral Blood Mononuclear Cells

Li, Y., Zhu, J., Tian, G., Li, N., Li, Q., Ye, M., Zheng, H., Yu, J., Wu, H., Sun, J., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000533 · Cited by 318

Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells.

Villar‐Garea, A., Fraga, M. F., Espada, J., & Esteller, M. (2003) · PubMed · Cited by 316

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells

Flotho, C., Claus, R., Batz, C., Schneider, M., Sandrock, I., Ihde, S., Plass, C., Niemeyer, C. M., & Lübbert, M. (2009) · Leukemia · doi:10.1038/leu.2008.397 · Cited by 315

Quantitation of GSTP1 Methylation in Non-neoplastic Prostatic Tissue and Organ-Confined Prostate Adenocarcinoma

Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., & Sidransky, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1747 · Cited by 306

Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1

Lee, B. H., Yegnasubramanian, S., Lin, X., & Nelson, W. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505593200 · Cited by 295

Molecular detection of prostate cancer in urine by GSTP1 hypermethylation.

Cairns, P., Esteller, M., Herman, J. G., Schoenberg, M., Jerónimo, C., Sánchez‐Céspedes, M., Chow, N. ‐., Grasso, M., Wu, L. J., Westra, W. B., et al. (2001) · PubMed · Cited by 294

Hypermethylation of the DNA Repair Gene O6-Methylguanine DNA Methyltransferase and Survival of Patients With Diffuse Large B-Cell Lymphoma

Esteller, M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.1.26 · Cited by 293

A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition

Ropero, S., Fraga, M. F., Ballestar, E., Hamelin, R., Yamamoto, H., Boix-Chornet, M., Caballero, R., Alaminos, M., Setien, F., Paz, M. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1773 · Cited by 290

CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.

Brooks, J. D., Weinstein, M. H., Lin, X., Sun, Y., Pin, S. S., Bova, G. S., Epstein, J. I., Isaacs, W. B., & Nelson, W. G. (1998) · PubMed · Cited by 282

A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma

Görgün, G., Calabrese, E., Hideshima, T., Ecsedy, J., Perrone, G., Mani, M., Ikeda, H., Bianchi, G., Hu, Y., Cirstea, D., et al. (2010) · Blood · doi:10.1182/blood-2009-12-259523 · Cited by 274

An evaluation of new criteria for CpG islands in the human genome as gene markers

Wang, Y., & Leung, F. C. C. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth059 · Cited by 267

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer

Agrelo, R., Cheng, W.-H., Setien, F., Ropero, S., Espada, J., Fraga, M. F., Herranz, M., Paz, M. F., Sanchez-Cespedes, M., Artiga, M. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600645103 · Cited by 264

Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer

Huang, Y.-W., Liu, J. C., Deatherage, D. E., Luo, J., Mutch, D. G., Goodfellow, P. J., Miller, D. S., & Huang, T. H.-M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1499 · Cited by 264

Quantitation of Promoter Methylation of Multiple Genes in Urine DNA and Bladder Cancer Detection

Hoque, M. O., Begum, S., Topaloglu, O., Chatterjee, A., Rosenbaum, E., Van Criekinge, W., Westra, W. H., Schoenberg, M., Zahurak, M., Goodman, S. N., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj265 · Cited by 262

CpG Island Hypermethylation of the DNA Repair Enzyme Methyltransferase Predicts Response to Temozolomide in Primary Gliomas

Paz, M. F., Yaya-Tur, R., Rojas-Marcos, I., Reynes, G., Pollan, M., Aguirre-Cruz, L., García-Lopez, J. L., Piquer, J., Safont, M.-J., Balaña, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0392 · Cited by 261

Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect

Lara, E., Mai, A., Calvanese, V, Altucci, L., Lopez-Nieva, P., Martinez-Chantar, M. L., Varela-Rey, M., Rotili, D., Nebbioso, A., Ropero, S., et al. (2009) · Oncogene · doi:10.1038/onc.2008.436 · Cited by 259

Effective Targeting of Quiescent Chronic Myelogenous Leukemia Stem Cells by Histone Deacetylase Inhibitors in Combination with Imatinib Mesylate

Zhang, B., Strauss, A. C., Chu, S., Li, M., Ho, Y., Shiang, K.-D., Snyder, D. S., Huettner, C. S., Shultz, L., Holyoake, T., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.011 · Cited by 256

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

Fernandez, A. F., Rosales, C., Lopez-Nieva, P., Graña, O., Ballestar, E., Ropero, S., Espada, J., Melo, S. A., Lujambio, A., Fraga, M. F., et al. (2009) · Genome Research · doi:10.1101/gr.083550.108 · Cited by 255

Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?

Dar, A. A., Goff, L. W., Majid, S., Berlin, J., & El-Rifai, W. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0765 · Cited by 249

Determination of enriched histone modifications in non-genic portions of the human genome

Rosenfeld, J. A., Wang, Z., Schones, D. E., Zhao, K., DeSalle, R., & Zhang, M. Q. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-143 · Cited by 245

A Phase 1 Pharmacokinetic and Pharmacodynamic Study of the Histone Deacetylase Inhibitor Belinostat in Patients with Advanced Solid Tumors

Steele, N. L., Plumb, J. A., Vidal, L., Tjørnelund, J., Knoblauch, P., Rasmussen, A., Ooi, C. E., Buhl-Jensen, P., Brown, R., Evans, T. R. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1786 · Cited by 244

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state

den Hollander, J., Rimpi, S., Doherty, J. R., Rudelius, M., Buck, A., Hoellein, A., Kremer, M., Graf, N., Scheerer, M., Hall, M. A., et al. (2010) · Blood · doi:10.1182/blood-2009-11-251074 · Cited by 242

Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects

Hoque, M. O., Topaloglu, O., Begum, S., Henrique, R., Rosenbaum, E., Van Criekinge, W., Westra, W. H., & Sidransky, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.009 · Cited by 240

The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type

Weigelt, B., Geyer, F. C., Natrajan, R., Lopez‐Garcia, M. A., Ahmad, A. S., Savage, K., Kreike, B., & Reis‐Filho, J. S. (2010) · The Journal of Pathology · doi:10.1002/path.2629 · Cited by 234

Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation

Sun, Y., Jiang, X., Chen, S., & Price, B. D. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.092 · Cited by 234

Epigenetic Reprogramming by Adenovirus e1a

Ferrari, R., Pellegrini, M., Horwitz, G. A., Xie, W., Berk, A. J., & Kurdistani, S. K. (2008) · Science · doi:10.1126/science.1155546 · Cited by 230

Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials

Ma, X., Ezzeldin, H. H., & Diasio, R. B. (2009) · Drugs · doi:10.2165/11315680-000000000-00000 · Cited by 227

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer

Li, M., Balch, C., Montgomery, J. S., Jeong, M., Chung, J. H., Yan, P., Huang, T. H., Kim, S., & Nephew, K. P. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-34 · Cited by 225

Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms

Chakravarti, A., Erkkinen, M. G., Nestler, U., Stupp, R., Mehta, M., Aldape, K., Gilbert, M. R., Black, P. M., & Loeffler, J. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0596 · Cited by 223

Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity

Stimson, L., Rowlands, M. G., Newbatt, Y. M., Smith, N. F., Raynaud, F. I., Rogers, P., Bavetsias, V., Gorsuch, S., Jarman, M., Bannister, A., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0135 · Cited by 223

Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma

Berdasco, M., Ropero, S., Setien, F., Fraga, M. F., Lapunzina, P., Losson, R., Alaminos, M., Cheung, N.-K., Rahman, N., & Esteller, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906831106 · Cited by 206

A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies.

Gilbert, J., Baker, S. D., Bowling, M. K., Grochow, L. B., Figg, W. D., Zabelina, Y., Donehower, R. C., & Carducci, M. A. (2001) · PubMed · Cited by 206

Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.

Segura-Pacheco, B. A., Trejo‐Becerril, C., Pérez‐Cárdenas, E., Taja‐Chayeb, L., Mariscal, I., Chavez, A., Acuña, C., Salazar, A. M., Lizano, M., & Dueñas‐González, A. (2003) · PubMed · Cited by 206

Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress

Isham, C. R., Tibodeau, J. D., Jin, W., Xu, R., Timm, M. M., & Bible, K. C. (2007) · Blood · doi:10.1182/blood-2006-07-027326 · Cited by 200

Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors

Hernandez-Vargas, H., Lambert, M.-P., Le Calvez-Kelm, F., Gouysse, G., McKay-Chopin, S., Tavtigian, S. V., Scoazec, J.-Y., & Herceg, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009749 · Cited by 199

Epigenetic inactivation of CHFR in human tumors

Toyota, M., Sasaki, Y., Satoh, A., Ogi, K., Kikuchi, T., Suzuki, H., Mita, H., Tanaka, N., Itoh, F., Issa, J.-P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1337066100 · Cited by 199

BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)- Ribose Polymerase Inhibitors

Veeck, J., Ropero, S., Setien, F., Gonzalez-Suarez, E., Osorio, A., Benitez, J., Herman, J. G., & Esteller, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1010 · Cited by 176

A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells

Kojima, K., Ohhashi, R., Fujita, Y., Hamada, N., Akao, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.045 · Cited by 175

Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of γ-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non–Small Cell Lung Cancer

Geng, L., Cuneo, K. C., Fu, A., Tu, T., Atadja, P. W., & Hallahan, D. E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0049 · Cited by 163

Promoter Methylation in APC, RUNX3, and GSTP1 and Mortality in Prostate Cancer Patients

Richiardi, L., Fiano, V., Vizzini, L., De Marco, L., Delsedime, L., Akre, O., Tos, A. G., & Merletti, F. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2485 · Cited by 160

MS-275, a potent orally available inhibitor of histone deacetylases—The development of an anticancer agent

Hess‐Stumpp, H., Bracker, T. U., Henderson, D. A., & Politz, O. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.009 · Cited by 156

Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy

Kantarjian, H. M., Giles, F. J., Greenberg, P. L., Paquette, R. L., Wang, E. S., Gabrilove, J. L., Garcia‐Manero, G., Hu, K., Franklin, J. L., & Berger, D. P. (2010) · Blood · doi:10.1182/blood-2010-03-274753 · Cited by 152

Discovery of Two Novel, Small-Molecule Inhibitors of DNA Methylation

Siedlecki, P. S., Boy, R. G., Musch, T., Brueckner, B., Suhai, S., Lyko, F., & Zielenkiewicz, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050844z · Cited by 146

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

Dejeux, E., Rønneberg, J. A., Solvang, H. K., Bukholm, I. K., Geisler, S. B., Aas, T., Gut, I. G., Børresen‐Dale, A., Lønning, P. E., Kristensen, V. N., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-68 · Cited by 143

Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer

Balch, C., Yan, P. S., Craft, T. R., Young, S. R. L., Skalnik, D. G., Huang, T. H. ‐., & Nephew, K. P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0216 · Cited by 141

IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer

de Cáceres, I. I., Cortés-Sempere, M., Moratilla, C., Machado-Pinilla, R., Rodríguez‐Fanjul, V., Manguán-García, C., Cejas, P., López‐Ríos, F., Paz-Ares, L. G., de CastroCarpeño, J., et al. (2009) · Oncogene · doi:10.1038/onc.2009.454 · Cited by 140

Epigenetic Multiple Ligands: Mixed Histone/Protein Methyltransferase, Acetyltransferase, and Class III Deacetylase (Sirtuin) Inhibitors

Mai, A., Cheng, D., Bedford, M. T., Valente, S., Nebbioso, A., Perrone, A., Brosch, G., Sbardella, G., Bellis, F. D., Miceli, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701595q · Cited by 137

The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells

Lucas, D. M., Davis, M. E., Parthun, M. R., Mone, A. P., Kitada, S., Cunningham, K. D., Flax, E. L., Wickham, J., Reed, J. C., Byrd, J. C., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403388 · Cited by 136

Low O 6 ‐methylguanine‐DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours

McCormack, A. I., McDonald, K. L., Gill, A. J., Clark, S. J., Burt, M. G., Campbell, K. A., Braund, W. J., Little, N., Cook, R., Grossman, A. B., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03487.x · Cited by 136

MS-qFRET: A quantum dot-based method for analysis of DNA methylationPreprint

Bailey, V. J., Easwaran, H., Zhang, Y., Griffiths, E. A., Belinsky, S. A., Herman, J. G., Baylin, S. B., Carraway, H. E., & Wang, T. (2009) · Genome Research · doi:10.1101/gr.088831.108 · Cited by 135

Expression profiling of sodium butyrate (NaB)-treated cells: identification of regulation of genes related to cytokine signaling and cancer metastasis by NaB

Joseph, J., Mudduluru, G., Antony, S., Vashistha, S., Ajitkumar, P., & Somasundaram, K. (2004) · Oncogene · doi:10.1038/sj.onc.1207852 · Cited by 127

DNA Methylation Based Biomarkers in Non-Invasive Cancer Screening

Shivapurkar, N., & Gazdar, A. F. (2010) · Current Molecular Medicine · doi:10.2174/156652410790963303 · Cited by 109

Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors

Steeghs, N., Eskens, F. A. L. M., Gelderblom, H. A. J., Verweij, J., Nortier, J. W. R., Ouwerkerk, J., van Noort, C., Mariani, M., Spinelli, R., Carpinelli, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6655 · Cited by 106

Isoform-Selective Histone Deacetylase Inhibitors

Suzuki, T., Itoh, Y., & Miyata, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208783885335 · Cited by 105

Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors

Beltrán, A. S., Parikh, S., Liu, Y., Cuevas, B. D., Johnson, G. L., Futscher, B. W., & Blancafort, P. (2006) · Oncogene · doi:10.1038/sj.onc.1210072 · Cited by 103

The MLL recombinome of adult CD10-negative B-cell precursor acute lymphoblastic leukemia: results from the GMALL study group

Burmeister, T., Meyer, C., Schwartz, S., Hofmann, J. P., Molkentin, M., Kowarz, E., Schneider, B., Raff, T., Reinhardt, R., Gökbuget, N., et al. (2009) · Blood · doi:10.1182/blood-2008-10-183483 · Cited by 97

Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer

Qian, X., Ara, G., Mills, E., LaRochelle, W. J., Lichenstein, H. S., & Jeffers, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.23243 · Cited by 93

Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy

Brueckner, B., Rius, M., Markelova, M. R., Fichtner, I., Hals, P., Sandvold, M. L., & Lyko, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1202 · Cited by 92

Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells

Terao, Y., Nishida, J.-I., Horiuchi, S., Rong, F., Ueoka, Y., Matsuda, T., Kato, H., Furugen, Y., Yoshida, K., Kato, K., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1448 · Cited by 91

Chromatin-modifying enzymes as therapeutic targets – Part 1

Keppler, B. R., & Archer, T. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1301 · Cited by 91

Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas

Ferreri, A. J. M., Dell’Oro, S., Capello, D., Ponzoni, M., Iuzzolino, P., Rossi, D., Pasini, F., Ambrosetti, A., Orvieto, E., Ferrarese, F., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05109.x · Cited by 87

Abrogation of MAPK and Akt Signaling by AEE788 Synergistically Potentiates Histone Deacetylase Inhibitor-Induced Apoptosis through Reactive Oxygen Species Generation

Yu, C., Friday, B. B., Lai, J.-P., McCollum, A. K., Atadja, P. W., Roberts, L. R., & Adjei, A. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1751 · Cited by 80

CpG Island Hypermethylation Profile in the Serum of Men With Clinically Localized and Hormone Refractory Metastatic Prostate Cancer

Bastian, P. J., Palapattu, G. S., Yegnasubramanian, S., et al. (2008) · The Journal of Urology · doi:10.1016/j.juro.2007.09.038 · Cited by 79

Promoter demethylation accompanies reactivation of theHOX11 proto-oncogene in leukemia

Watt, P. M., Kumar, R. G., & Kees, U. R. (2000) · Genes Chromosomes and Cancer · Cited by 77

In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates

Marchion, D. C., Biçaku, E., DAUD, A. I., Sullivan, D. M., & Münster, P. N. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0194 · Cited by 74

Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU)

Beumer, J. H., Parise, R. A., Newman, E. M., Doroshow, J. H., Synold, T. W., Lenz, H., & Egorin, M. J. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0603-8 · Cited by 72

The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression

Chen, S., Ye, J., Kijima, I., & Evans, D. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000917107 · Cited by 58

An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes

Godley, L. A., García, & Jain (2010) · OncoTargets and Therapy · doi:10.2147/ott.s7222 · Cited by 47

Recruitment of CBP/p300, TATA-Binding Protein, and S8 to Distinct Regions at the N Terminus of Adenovirus E1A

Rasti, M., Grand, R. J. A., Mymryk, J. S., Gallimore, P. H., & Turnell, A. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5594-5605.2005 · Cited by 42

MOZ and MOZ-CBP cooperate with NF-κB to activate transcription from NF-κB–dependent promoters

Chan, E. M., Chan, R. J., Comer, E. M., Goulet, R. J., Crean, C., Brown, Z. D., Fruehwald, A. M., Yang, Z., Boswell, H. S., Nakshatri, H., et al. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.07.015 · Cited by 39

Cancer epigenetics is no Mickey Mouse

Feinberg, A. P. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.014 · Cited by 38

Tumor O6-methylguanine-DNA Methyltransferase Inactivation by Oral Lomeguatrib

Watson, A. J., Sabharwal, A., Thorncroft, M. R., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1389 · Cited by 34

Low concentrations of the histone deacetylase inhibitor, depsipeptide, enhance the effects of gemcitabine and docetaxel in hormone refractory prostate cancer cells

Kanzaki, M., Kakinuma, H., Kumazawa, T., Inoue, T., Saito, M., Narita, S., Yuasa, T., Tsuchiya, N., & Habuchi, T. (2007) · Oncology Reports · doi:10.3892/or.17.4.761 · Cited by 30

The silent estrogen receptor--can we make it speak?

Billam, M., Witt, A. E., & Davidson, N. E. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.6.7582 · Cited by 18

Non-coding RNAs in human disease

Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825

Regulatory networks defining EMT during cancer initiation and progression

Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487

Wnt signaling in cancer.

Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847

Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers

Okugawa, Y., Grady, W. M., & Goel, A. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.011 · Cited by 782

Distinct DNA methylomes of newborns and centenarians

Heyn, H., Li, N., Ferreira, H. J., Moran, S., Pisano, D. G., Gomez, A., Diez, J., Sanchez-Mut, J. V., Setien, F., Carmona, F. J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120658109 · Cited by 802